Ciphergen s Q2 Earnings Unreliable as Auditors Investigate Other Periods; Problem Not Likely Nefarious | GenomeWeb

NEW YORK, Nov. 17 (GenomeWeb News) - Ciphergen Biosystems' second-quarter earnings report should "no longer be relied upon" and should be restated after the company last week brought into question the validity of around $500,000 in revenue from that period, Ciphergen said yesterday.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.